Validity of an Online Neurocognitive Test Battery, the Brain Performance Test (BPT), in Normal Healthy Adults

- Native English speaker

- Capable and willing to provide informed consent

- Able to use a computer and mouse without assistance

- Limited (< 3 days) or no experience with Lumosity.com

- Limited (< 3 days) or no experience with other cognitive training programs (e.g., FitBrains, CogMed)

- Willing to refrain from online cognitive training during the course of the study

- No recent (<1 years) experience with either computer-based or in-person neuropsychological tests (e.g., WAIS-IV, WISC, Halstead-Reitan Battery, MATRICS, CogState, CNS Vital Signs)

- Good general health assessed via self-reported online physical questionnaire and medical history questionnaire

- Illiterate or unable to understand written English sufficiently to comprehend study instructions and consent form

- Uncorrected visual impairment (beyond that required to qualify for a California Driver's License) that may impact the ability to complete assessments (self-report or determined by the clinician)

- Uncorrected auditory impairment that may impact the ability to complete assessments (self-report or determined by the clinician)

- Self-reported clinical diagnosis for primary psychiatric or neurological disorder (e.g., schizophrenia, multiple sclerosis, attention deficit hyperactivity disorder, Parkinson's disease, epilepsy)

- Self-reported history of concussion or traumatic brain injury, that is considered clinically significant in the opinion of the investigator (e.g. loss of consciousness ≤ 30 minutes)

- Self-reported diagnosis of mental retardation or pervasive developmental disorder

- Self-reported diagnosis of Mild Cognitive Impairment, Alzheimer's disease, or other dementia

- Self-reported history of sustained substance or alcohol abuse or dependence, that is considered clinically significant in the opinion of the investigator (e.g. as defined by DSM-5)

- Self-report that subject is currently taking an antipsychotic, antidepressant, anti-anxiety, or a cognitively-enhancing medication (e.g. Ritalin), or in the last 72 hours, narcotics for pain or other medications that may impact cognitive performance (e.g. sleeping medications/aides or cold/allergy medications)

- Any other significant medical condition that could impact cognitive performance or result in cognitive impairment in the opinion of the investigator

- Score <28 on the MMSE

- Positive urine test for recent substance use on either testing day

- Breath Alcohol Content of 0.01% or greater on either testing day